Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants
NCT06912295
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
HL-1186
DRUG:
HL-1186 placebo
Sponsor
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.